• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

    Reed-Lane Facility Virtual Tour
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Data Management Trends

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Cytovance Biologics

    Aphena Pharma Solutions

    Almac Group

    Reed-Lane

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Adare Pharma Solutions

    Almac Group

    Syngene

    PCI Pharma Services

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    Pitfalls to Avoid When Packaging Injectable Drug Products

    Addressing legacy systems, lack of innovation adoption, and special challenges of New Molecular Entities.

    Pitfalls to Avoid When Packaging Injectable Drug Products
    Related CONTENT
    • Biopharma Over 20 Years
    • CPhI Pharma Machinery Report: Critical time to invest in machinery with changing drugs pipeline
    • Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
    • Vetio Animal Health
    • Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution
    Fran DeGrazio, VP, Scientific Affairs and Technical Services, West Pharmaceutical Services11.20.19
    When bringing a new injectable drug product to market, the packaging is quite important, especially considering the potential problems that can result with stability, manufacturing, or use. In today’s regulatory climate, it is essential to have a heightened awareness of all the risks that can occur, from development through lifecycle. This article will cover four pitfalls to avoid when packaging drug products.

    Many manufacturers of new drug products, in particular biologics, use legacy components for packaging, i.e., components they have used over time and with other drug products. This is based on the assumption that packaging components are inert, or that issues can be overcome by reformulation. These legacy components appear to offer the benefits of known performance and supply chain and resultant smooth production with minimal downtime. But legacy components may not meet the quality and regulatory standards of today, which require understanding of potential risks for each individual pairing of drug product and container closure system (CCS). In particular, the factors that impact protection, compatibility, safety, and performance, is required.

    For example, an ongoing risk to injectable drug products is particles in solution. Particles can result through many ways, such as various incompatibilities, contamination sources like production environment, or insufficient washing. An awareness by drug manufacturers of these issues is essential, particularly knowledge of new options in CCS packaging components, and their ability to mitigate particle issues and help to meet the rigorous quality and regulatory standards of today.

    This pitfall relates to Pitfall-1, although the industry is very interested in innovations, their ability to adopt them is quite slow. The “pain” resultant from non-adoption must be quite visible throughout an organization in order to gain the alignment by all functions needed to drive adoption of an innovation.  Of course, there can be major advantages for those who are first movers and are willing to engage in the activities needed for adoption of innovations. This can be greatly promoted through partnerships with the suppliers/owners of a platform or technology. Suppliers can help guide critical product requirements without the drug manufacturer needing to fund a specific development program; suppliers receive useful input from the manufacturers to assure a product will meet industry needs.

    One might argue that the barriers to innovation adoption lie in the drug R&D process itself, particularly in the way that scientists and engineers relate to supporting functions such as information technology, intellectual property, legal, procurement/supply chain, operations, regulatory and quality assurance. Ultimately, innovation may be blocked by individuals who cannot exchange information in an understandable way among the various functions, resulting in an inability to convey the importance of the innovation. This challenge, coupled with the frequent lack of clarity as to decision making ownership, and the normal risk aversion due to potential regulatory challenges, is central.

    There is an increasing awareness, especially among device engineers and regulatory personnel, on the subject of drug/device combination products, in particular the Quality System regulations specified in 21 CFR 820. The challenge, however, is that historically the industry has been focused on the drug product and package—not the delivery device. Therefore, there was limited understanding of the technical, developmental, and regulatory requirements to meet current combination product best practices, which means combining both the drug and device CGMP regulations.  In fact, until the last several years, there was still confusion around the fact that prefilled syringe systems are combination products. This is now noted in several areas on the FDA website and associated combination product guidances. Building this type of awareness takes time.

    In some cases, the drug formulation development group is choosing the packaging system—which later may be part of a combination product—even if it begins as a traditional vial system. Quite often reconstitution/transfer systems are used with vials, for example, convenience kits that include a drug product in a vial with a vial adapter. Such a kit is considered a combination product in the North American market. This example highlights that both drug and device CGMPs must be followed from the beginning of the development process. Failure to do so can put many products at risk from the standpoint of regulatory approval.

    There is a growing complexity to the molecular entities in the industry’s pipeline. Many manufacturers, who had focused on small molecule drug products, are expanding into large molecule biologics, such as monoclonal antibodies (mAbs). mAbs comprise the majority of biologics both in development and commercialized. This pipeline is becoming more diverse, with the emergence of therapies based on technologies such as gene, siRNA, oligonucleotides or stem cells. There may be unique needs for these new drug products, and packaging/delivery requirements (sensitivities, storage/delivery) may be quite different. Thus, it is essential that the starting point for all packaging be the needs of the molecular entity—to ensure suitability and ultimately safe delivery to the patient. 
    Related Searches
    • pipeline
    • cGMP
    • Formulation Development
    • Stability
    Suggested For You
    Biopharma Over 20 Years Biopharma Over 20 Years
    CPhI Pharma Machinery Report: Critical time to invest in machinery with changing drugs pipeline CPhI Pharma Machinery Report: Critical time to invest in machinery with changing drugs pipeline
    Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
    Vetio Animal Health Vetio Animal Health
    Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution
    Quality Metrics Feedback Quality Metrics Feedback
    FDA Extends CRADA with CluePoints FDA Extends CRADA with CluePoints
    Four Pitfalls to Avoid When Packaging Injectable Drug Products Four Pitfalls to Avoid When Packaging Injectable Drug Products
    NIIMBL, FDA to Advance Innovation in Bio Manufacturing NIIMBL, FDA to Advance Innovation in Bio Manufacturing
    FDA Accepts RedHill Biopharma’s NDA for Talicia FDA Accepts RedHill Biopharma’s NDA for Talicia
    The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up? The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?
    Sierra’s Momelotinib Granted FDA Fast Track Designation Sierra’s Momelotinib Granted FDA Fast Track Designation
    Risk-Based Monitoring Risk-Based Monitoring
    The Orphan Promise The Orphan Promise

    Related Back Page

    • Aseptic Processing | Facilities | Fill/Finish | Parenterals
      The Future of Pharmaceutical Manufacturing

      The Future of Pharmaceutical Manufacturing

      Innovative multi-product facility and equipment design.
      Steve Nole, VP of Operations, Grand River Aseptic Manufacturing 01.27.21

    • Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Supply chain management for cell and gene therapies requires precise demand planning and forecasting.
      Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | R&D
      The Global Biotech Boom

      The Global Biotech Boom

      How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.
      Davide Garrisi, PPD Biotech 09.09.20


    • Speeding Vaccine Development with Advanced Analytics

      Speeding Vaccine Development with Advanced Analytics

      Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development process
      Dr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 05.05.20

    • APIs
      SOPs to Spur Growth in API Manufacturing

      SOPs to Spur Growth in API Manufacturing

      CMOs see outsourcing prospects improve
      S. Harachand, Contributing Editor 04.01.20

    • Trends Affecting the Generic Drugs Sector in 2020

      Trends Affecting the Generic Drugs Sector in 2020

      Supply chain issues, the need for additional talent chemists, lower drug prices, growth of development in the U.S. will be key factors.
      Ed Price, President, Seqens NA 03.04.20


    • QA/QC
      Quality Management: Preserving and Perpetuating Your Record

      Quality Management: Preserving and Perpetuating Your Record

      CDMOs must ensure that their top priority be delivering the highest quality products.
      Colleen Herczak, Vice President of Quality, Grand River Aseptic Manufacturing 01.28.20

    • Information Technology
      Data Management in Life Sciences: Then and Now

      Data Management in Life Sciences: Then and Now

      A look at landmark changes in the management of data in the life sciences over the last 20 years and how the industry has addressed the challenges these develop
      Jason Lacombe, CEO, Veratrak 10.15.19

    • Clinical Trials | Information Technology
      Virtual Trials: Are they living up to their hype?

      Virtual Trials: Are they living up to their hype?

      This innovative approach is less costly, more patient-friendly, and delivers better quality data however, many stakeholders are still uncertain
      Josh Rose, VP R&D Global Strategy and Head of Virtual Trial Solutions, IQVIA 09.16.19


    • Avoiding Death by Spreadsheet

      Avoiding Death by Spreadsheet

      Cloud ERP systems are ushering in a new era of supply chain management
      Michael Kolias, QAD 06.13.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biotech Booms in the Yangtze River Valley

      Biotech Booms in the Yangtze River Valley

      A look at forces shaping the course of biotech growth in China
      Daniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19

    • India Eases Price Control  On Novel Drugs

      India Eases Price Control On Novel Drugs

      No price cap for innovator products for 5 years
      S. Harachand, Contributing Editor 03.06.19


    • Logistics | Supply Chain
      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      The role of pharmaceutical distributors in the increasingly complex supply chain
      Akin Odutola, AmerisourceBergen 01.25.19

    • Injectables | Parenterals
      Injectables Go Deeper

      Injectables Go Deeper

      Generic majors set sights on complex sterile injectables
      S. Harachand, Contributing Editor 11.14.18

    • Biologics, Proteins, Vaccines | Clinical Trials
      Getting to First-in-Human Clinical Trials

      Getting to First-in-Human Clinical Trials

      A make-or-break milestone for small biopharmas
      David Kenyon, Patheon 10.10.18

    Trending
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • Reed-Lane Facility Virtual Tour
    Breaking News
    • AGC Biologics Expands Cell and Gene Facility in Italy
    • Celonic to Boost Cell & Gene Therapy Production
    • Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    • Aptamer Extends Collaboration with AstraZeneca
    • Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ulta Beauty Opens in Herald Square
    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Indie Beauty Innovators Wanted
    Cosmetic Chemists Seek Mentors
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login